PRKAA1 and peripheral arterial disease: (b) In vitro, Drp1KO BMDMs exposed to HSS, an in vitro model of PAD, showed enhanced glycolytic activity due to reduced p-AMPK, along with mitochondrial dysfunction and excess mitoROS production, leading to increased M1 and decreased M2 gene expression.